REVIMMUNE
Live / Applied — Fourth extension granted (statement of use) (as of 18 Jun 2025)
What this means for you
Not registered yet, but its 26 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97430154
- Mark type
- Stylized text
- Filed
- 26 May 2022
- Published for opposition
- 02 May 2023
- Attorney of record
- Michael A. Geller
Goods and services
- Class 005 — Pharmaceuticals: Biological and pharmaceutical preparations, namely, biological and pharmaceutical preparations and substances for the prevention and treatment of blood disease and cancer, viral and other infectious diseases, and the modulation and treatment of immune system related diseases and disorders
Owner
- RevImmune, Inc., Bethesda, MD, US
- RevImmune, Inc., Bethesda, MD, US
Prior registrations
Prosecution history
- 17 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2025 — SOU EXTENSION 4 GRANTED
- 18 Jun 2025 — SOU EXTENSION 4 FILED
- 18 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Dec 2024 — SOU EXTENSION 3 GRANTED
- 04 Dec 2024 — SOU EXTENSION 3 FILED
- 04 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 23 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 May 2024 — SOU EXTENSION 2 GRANTED
- 22 May 2024 — SOU EXTENSION 2 FILED
- 22 May 2024 — SOU TEAS EXTENSION RECEIVED
- 24 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Nov 2023 — SOU EXTENSION 1 GRANTED